ROBERT VALENTINE: Open Payments
NPI 1730164161 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,453 in 58 payments from 20 companies in 2025. Trend: 2023 $1,064 · 2024 $1,562 · 2025 $1,453
Food & beverage: $1,453
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 5 | $319 |
| Collegium Pharmaceutical, Inc. | 15 | $283 |
| TerSera Therapeutics LLC | 8 | $200 |
| Averitas Pharma Inc. | 5 | $150 |
| ABBVIE INC. | 4 | $80 |
| PFIZER INC. | 3 | $59 |
| Saluda Medical Americas, Inc. | 2 | $49 |
| Boston Scientific Corporation | 2 | $40 |
| Azurity Pharmaceuticals, Inc. | 2 | $40 |
| Valinor Pharma, LLC | 2 | $35 |
Products named: SYNCHROMEDII, Prialt, Belbuca, QUTENZA, XTAMPZA, INCEPTIV, NURTEC ODT, Evoke.
Industry payments across FL — which companies pay providers there.
